Comments
Loading...
ArriVent BioPharma (AVBP) Forecast
NewsEarningsArriVent BioPharma (AVBP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestArriVent BioPharma (NASDAQ:AVBP) Stock Quotes, Forecast and News Summary
ArriVent BioPharma Stock (NASDAQ: AVBP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ArriVent BioPharma (AVBP) stock?
You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.
Who are ArriVent BioPharma (AVBP) competitors?
There are no as such competitors for ArriVent BioPharma.
What is the forecast, or price target, for ArriVent BioPharma (AVBP) stock?
ArriVent BioPharma has a consensus price target of $37.40.
What is the current price for ArriVent BioPharma (AVBP)?
The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $29.02 last updated January 29, 2025 at 4:00 PM EST.
Does ArriVent BioPharma (AVBP) pay a dividend?
There are no upcoming dividends for ArriVent BioPharma.
When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?
ArriVent BioPharma’s Q4 earnings are confirmed for Monday, February 10, 2025.
Is ArriVent BioPharma (AVBP) going to split?
There is no upcoming split for ArriVent BioPharma.
What sector and industry does ArriVent BioPharma (AVBP) operate in?
ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.